When you absolutely have to recruit patients on time
Home Our Locations
BUILD A DIVERSE TRIAL GEOGRAPHY FOR IMPROVED PERFORMANCE
Uniquely positioned in an attractive region for conducting multinational, multicenter clinical trials, we offer you local clinical staff in each country, directed by our strong and responsive central project management. Diversifying the clinical trial locations can be a part of a successful recruitment and retention strategy. Our region offers hundreds of clinical sites, all compliant with global industry standards. Accell’ robust, across-the-board Standard Operating Procedures ensure compliance to the full extent across all operating geographies.
Clinical trials approval in 30-60 days
On average, it takes a total between 4 and 5 months for Accell’s team to start-up a trial. Regulatory assessment is always a part of our strategy.
Regulatory agency recognition
About 60% of clinical trial data included in MA applications to the EMA has been generated outside the EU. We work in EU countries, as well as non-EU countries fully compliant with ICH E6 Guidelines.
Patient access
We offer unparalleled access to centralized and specialized healthcare and sites with high treatment capacity. This allows trial sponsors to recruit 6-10 times faster than at sites set in a private practice.
Strategic thinking
Our country selection approach revolves around building strong relationships with hundreds of centralized, multidepartment hospitals in various indications. Stringent investigator selection criteria help ensure our projections are met.
Our Locations
Accell’s global clinical trials capabilities
▼Roll the cursor over each country to see the number of registered clinical trials. List of all registered studies is available at ClinicalTrials.gov.▼
• Russia has 1 clinical trial for every 38,000 people.
discover our region country by country
Belarus
Non-EU
60 days for regulatory approval
9.5 million population
Bulgaria
EU
60 days for regulatory approval
7.1 million population
Croatia
EU
60 days for regulatory approval
4.1 million population
Estonia
EU
60 days for regulatory approval
1.3 million population
Georgia
Non-EU
28-56 days for regulatory approval
3.7 million population
Hungary
EU
60 days for regulatory approval
9.8 million population
Kazakhstan
Non-EU
10 business days for regulatory approval | 17.8 million population
Latvia
EU
60 days for regulatory approval
1.96 million population
Lithuania
EU
60 days for regulatory approval
2.8 million population
Montenegro
EU
60 days for regulatory approval
622 781 population
Poland
EU
75 days for regulatory approval
37.95 million population
Romania
EU
60 days for regulatory approval
19.71 million population
Russia
Non-EU
60 days for regulatory approval
144.3 million population
Serbia
EU
60 days for regulatory approval
7 million population
Ukraine
Non-EU
60 days for regulatory approval
45 million population
Israel
Non-EU
60-90 days for regulatory approval
8.7 million population
USA
North America
30-90 days for regulatory approval
327.2 million population
Explore the country
This Is Your Team. We Make Clinical Trials Happen.
